Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Total Liabilities (2016 - 2025)

Aspen Aerogels' Total Liabilities history spans 13 years, with the latest figure at $171.2 million for Q4 2025.

  • For the quarter ending Q4 2025, Total Liabilities fell 38.97% year-over-year to $171.2 million, compared with a TTM value of $171.2 million through Dec 2025, down 38.97%, and an annual FY2025 reading of $171.2 million, down 38.97% over the prior year.
  • Total Liabilities for Q4 2025 was $171.2 million at Aspen Aerogels, down from $185.7 million in the prior quarter.
  • The five-year high for Total Liabilities was $280.4 million in Q4 2024, with the low at $33.2 million in Q1 2021.
  • Average Total Liabilities over 5 years is $176.5 million, with a median of $195.7 million recorded in 2022.
  • Year-over-year, Total Liabilities skyrocketed 379.66% in 2022 and then tumbled 38.97% in 2025.
  • Tracing ASPN's Total Liabilities over 5 years: stood at $54.5 million in 2021, then skyrocketed by 259.29% to $196.0 million in 2022, then grew by 9.7% to $215.0 million in 2023, then soared by 30.44% to $280.4 million in 2024, then tumbled by 38.97% to $171.2 million in 2025.
  • Per Business Quant, the three most recent readings for ASPN's Total Liabilities are $171.2 million (Q4 2025), $185.7 million (Q3 2025), and $216.4 million (Q2 2025).